The Pfizer-BioNTech COVID-19 vaccine gets Emergency Use Authorization for booster doses in certain individuals; A smaller vaccine dose appears safe and effective in children; A survey sheds light on parents’ thoughts on child COVID vaccination; Janssen share booster data for their vaccine; Remdesivir efficacy data in COVID-19 patients, And Opzelura is approved for atopic dermatitis.
The survey asked about the likelihood of both child and parental vaccination, perceptions about the vaccines and the level of trust in various sources of information.
Higher body mass index tied to poor response to inhaled corticosteroids
The expanded approval was based on data from adequate and well-controlled phase 3 studies as well as an open-label safety study in adolescents.
Participants 5 to 11 years of age received a 2-dose regimen of 10mcg administered 21 days apart.
Despite 79.9 percent increase in parent-reported safety concerns, there was a drop in HPV vaccine-related reported adverse reactions
Findings seen in secondary analysis of data for children randomly assigned to adenotonsillectomy or watchful waiting for nonsevere OSA
Those abstaining from screen time had nearly five days shorter duration of symptoms
Multrys is supplied in 1mL single-dose vials containing zinc 1000mcg, copper 60mcg, manganese 3mcg, and selenium 6mcg.
Krabbe disease is a rare inherited disorder caused by mutations in the GALC gene.
